Trade Idea: GILD
I am BEARISH on $Gilead Sciences(GILD)$ at its current levels.
Here's a look at its daily chart:
The stock failed to break above 90, which was the same spot where it failed back in January 2018 - back then, it made a high of 89.54 before pulling back over 25 points. This suggests that 90 is an extremely strong historical resistance level for the stock. The stock hit the upper Bollinger Band a few days ago on the attempt to break 90, which signified the start of a short opportunity from there. Currently, it has broken the middle Bollinger Band which suggests that a strong downside move is coming in the coming days. I am inclined to lean bearish on the contracting Bollinger Bands, with increased volume on yesterday's red candle. I have plotted the fibonacci retracement levels on the chart above. Minimally, I'm looking for a downside move to 83s. Ultimately, I'm targeting the gap fill back to 70s from back in October.
That being said, the stock has been holding support at the 20DMA and the 21EMA since September. Breaking both of these likely signal the start of a pullback. I have gotten some puts expiring in February 2023, in anticipation of the gap filling by then. While there were rumblings of a merger with $AstraZeneca PLC(AZN)$ back in June 2020, those rumblings have not materialised and I expect such rumours to be insignifcant in the longer term.
So, how do you trade this stock? You can get 85P expiring in early January (i.e. 4-5 weeks out). If you're worried about any upside move, then you can hedge with 87C that has the same expiry (smaller size as compared to puts). In other words, a strangle strategy. If the broader market bounces, it's possible that the stock might get a lift from here, however, the chart sure does look like it's going to roll over in the short term similar to $Amgen(AMGN)$ . Good luck everyone!
If you enjoyed this post, then leave a like and/or a comment on my post and follow me for more of such posts!
@TigerWire @TigerStars $SPDR S&P 500 ETF Trust(SPY)$ $Spdr S&P Biotech Etf(XBI)$
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- nimbly·2022-12-16TOPIt seems that GILD is hitting a wall around $89.7Report
- didiling·2022-12-16TOPthanks for sharing5Report
- JuliusGoldsmith·2022-12-16TOPAre there any chances to break the historical resistance level? looks hard if simply wacthing at the volume6Report
- bubblyx·2022-12-16TOPIf you notice, Gilead was probably one of the only profitable Pharma that didn't make a new All time high this year.6Report
- cheerzy·2022-12-16To me GILD is a recession-proof stock, like ADM, NTR.4Report
- Trevelyan·2022-12-16So high it can touch the sky.. as well as the thunder which can point it down...2Report
- Aqa·2022-12-18May i check how di you make the ‘Neutral/Short vote’ game at the bottom of your post? Thanks v1Report
- bullditt·2022-12-16Great ariticle, would you like to share it?2Report
- DaveLewis·2022-12-16Looks like an inverted U-shaped trend.LikeReport
- Gloria112·2022-12-16gonna roll over. strangle strategy is 👍goodLikeReport
- TBITrades·2022-12-16woops sorry guys. I messed up the poll. [Happy]LikeReport
- x2espresso·2022-12-16I m bearish too.LikeReport
- Irene lee·2022-12-19OkLikeReport
- kktan·2022-12-19okLikeReport
- Newnew·2022-12-19HiLikeReport
- Unknown934·2022-12-19Eow1Report
- Siti Saniah·2022-12-19ok1Report
- 211013能量飞车·2022-12-18👍LikeReport
- Jean0031·2022-12-18LikeLikeReport
- Alisont09·2022-12-18Nice1Report